AML-NET : Acute Myeloid Leukemia treated with with NETrin Abs in combination with [AZACITIDINE + VENETOCLAX]

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503408-10-00

Acronym

ET23-026

Enrollment

Registered

2023-08-25

Start date

2024-09-08

Completion date

2025-07-04

Last updated

2025-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Acute Myeloïd Leukemia

None listed

Sex/Gender

All

Age

65 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026